📰 Nasdaq Celc News
Nasdaq Celc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Celc. Real-time updates on events, politics, business and more.
February 24, 2024
Pale Fire Capital SE acquired a new position in Celcuity Inc. (NASDAQ:CELC – Free Report) during the third quarter, HoldingsChannel reports. The institutional investor acquired 10,409 shares of the company’s stock, valued at approximately $95,000. A number of other large investors have also added to or reduced their stakes in CELC. Barclays PLC bought a […]
January 28, 2024
Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 865,600 shares, an increase of 21.1% from the December 31st total of 714,600 shares. Based on an average daily trading volume, of 115,600 shares, […]
January 17, 2024
Jacob Asset Management of New York LLC lessened its holdings in Celcuity Inc. (NASDAQ:CELC – Free Report) by 4.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 63,209 shares of the company’s stock after selling 3,000 shares during the quarter. Jacob Asset […]
December 31, 2023
Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 481,400 shares, an increase of 27.8% from the November 30th total of 376,800 shares. Based on an average daily volume of 80,400 shares, the […]
December 10, 2023
HC Wainwright began coverage on shares of Celcuity (NASDAQ:CELC – Get Free Report) in a research report issued on Friday, Marketbeat.com reports. The firm set a “buy” rating and a $27.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 82.68% from the company’s current price. Separately, Needham & Company […]
December 10, 2023
Commodore Capital LP lifted its holdings in shares of Celcuity Inc. (NASDAQ:CELC – Free Report) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,444,141 shares of the company’s stock after buying an additional 53,369 shares during the period. […]
December 4, 2023
Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 366,900 shares, a drop of 10.6% from the October 31st total of 410,300 shares. Based on an average trading volume of 61,300 shares, the […]
November 22, 2023
MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...
November 1, 2023
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted...
September 24, 2023
Celcuity (NASDAQ:CELC – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk. Valuation and Earnings This table compares Celcuity […]